Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,990 | 9,302 | 14,361 | 19,609 | 9,965 |
| TOTAL | $6,806 | $10,088 | $14,551 | $19,945 | $10,265 |
| Non-Current Assets | |||||
| PPE Net | 101 | 113 | 121 | 135 | 140 |
| Investments And Advances | 50 | 50 | 50 | 50 | 50 |
| Other Non-Current Assets | 1,407 | 1,419 | 1,596 | 1,689 | 1,780 |
| TOTAL | $1,558 | $1,582 | $1,767 | $1,874 | $1,970 |
| Total Assets | $8,364 | $11,670 | $16,318 | $21,819 | $12,235 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,041 | 4,598 | 5,131 | 4,701 | 5,318 |
| TOTAL | $4,710 | $5,344 | $5,541 | $5,178 | $5,855 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 504 | 531 | 670 | 749 | 827 |
| TOTAL | $634 | $682 | $841 | $940 | $1,037 |
| Total Liabilities | $5,344 | $6,026 | $6,382 | $6,118 | $6,892 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,159 | 10,101 | 5,485 | 5,409 | 5,396 |
| Common Shares | 175 | 5 | 165 | 162 | 119 |
| Retained earnings | -214,428 | -208,758 | -204,155 | -197,556 | -192,528 |
| TOTAL | $3,020 | $5,644 | $9,936 | $15,701 | $5,343 |
| Total Liabilities And Equity | $8,364 | $11,670 | $16,318 | $21,819 | $12,235 |